Jade Biosciences, Inc. (JBIO)
19.83
-1.57
(-7.34%)
USD |
NASDAQ |
Sep 03, 16:00
19.83
0.00 (0.00%)
After-Hours: 20:00
Jade Biosciences Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -1.31K% |
| Cue Biopharma, Inc. | 99.54% |
| Praxis Precision Medicines, Inc. | -- |
| Opus Genetics, Inc. | 98.15% |
| Faeth Therapeutics, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -52.85% |
| Return on Assets | -48.87% |
| Return on Invested Capital | -52.72% |
| Return on Net Operating Assets | -17.51K% |